#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
We are currently enrolling patients in the BEAR (TM) II study. To learn more about the BEAR (TM) II trial or to schedule an appointment with a BEAR(TM) trial physician, please call 617-355-3501 or email firstname.lastname@example.org.
Patients eligible for the study:
• will be ages 14 to 35, but need to have closed growth plates
• will have a complete ACL tear which occurred in the past 30 days
• cannot have a history of prior surgery on the affected knee
• must not use tobacco, corticosteroids or have a history of diabetes
or inflammatory arthritis
• must not have an allergy to bovine collagen (cow protein)
Patients will be randomly assigned to have the BEAR (TM) procedure (two-thirds of patients) or a standard ACL reconstruction (one-third of patients) and will not be told which group they are in until two years after their surgery.
For more information download the brochure or to learn more about the BEAR (TM) trial email us at email@example.com.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”